VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Award
Common Stock
2022-12-16+1,651→ 324,083 total - Award
Non-Qualified Stock Option (right to buy)
2022-12-16+16,254→ 16,254 totalExercise: $726.53Exp: 2032-12-16→ Common Stock (16,254 underlying)
Holdings
- 126,043(indirect: by CLAT)
Common Stock
- 2,102(indirect: By 401(k))
Common Stock
- 23,461(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
- [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.